UroGen Pharma Ltd. (URGN) forecast
UroGen Pharma Ltd. (URGN) forecast: price $34.76, trailing P/E -17.68, forward P/E 12.20. How to read the street's path.
The live URGN price is $34.76. Trailing P/E is -17.68 and forward P/E is 12.20. The forecast that matters is the earnings path those ratios imply, not a single target price.
A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.
Use this page for the URGN forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.
Learn: Forward P/E · Analyst forecast · DCF
Full URGN quote · Dividends · Price prediction · Academy
Questions
What is URGN's forward P/E?
The latest forward P/E on Stocklytics is 12.20, against a trailing P/E of -17.68 and a price of $34.76.
Is the analyst target the forecast?
It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.